Thomas Johnson is an Ophthalmology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Wilmer Eye Institute, Johns Hopkins Hospital
600 North Wolfe Street, Wilmer B-29
Baltimore, MD 212870001
Telephone
410-955-5650Registry record last updated 18 Jan 2019.
Clinical trials
- ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)
Sponsor: IHF GmbH - Institut für Herzinfarktforschung
- Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules
Sponsor: Johnson Thomas
- Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
Sponsor: The National Retina Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Alcon Vision LLCProgram year20241 payment
- Alcon Vision LLCProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
93.4%Prostaglandin Analog37.5%Latanoprost80%Travoprost7%Lumigan6%Tafluprost3%Travatan Z2%Zioptan2%Part D<11 patientsCarbonic Anhydrase Inhibitor28.1%Dorzolamide-Timolol83%Dorzolamide Hcl11%Simbrinza6%Part D<11 patients+ 5 more classes in this area
Cardiovascular
5.1%Beta blocker5.1%Timolol Maleate100%Part D≥28 patientsCancer & immunology
0.8%Calcineurin inhibitor0.8%Restasis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Mechanisms of functional retinal engraftment by transplanted retinal ganglion cells
Johns Hopkins University
FY2026$698,999R01EY038765 - Transplantation of human stem cell-derived neurons for retinal ganglion cell replacement and optic nerve regeneration.
Johns Hopkins University
FY2024$189,203K08EY031801 - Visualizing functional retinal integration of transplanted retinal ganglion cells
Johns Hopkins University
FY2023$204,688R21EY034332
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”